Century Therapeutics Ownership 2024 | Who Owns Century Therapeutics Now?
Institutional Ownership
3.14%
Insider Ownership
28.21%
Retail Ownership
68.64%
Institutional Holders
16.00
Century Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 8.68% | 1.51% | 5,410,361 | 5,410,361 | 100.00% | 13,796,421 | Jun 30, 2024 |
| VR ADVISER, LLC | 8.65% | 0.88% | 5,389,259 | 1,984,126 | 58.27% | 13,742,610 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 7.87% | 0.66% | 4,901,603 | 3,151,603 | 180.09% | 12,499,088 | Jun 30, 2024 |
| CASDIN CAPITAL, LLC | 5.15% | 0.63% | 3,206,380 | - | - | 8,176,269 | Jun 30, 2024 |
| FMR LLC | 4.74% | 0.00% | 2,950,279 | -420,949 | -12.49% | 7,523,211 | Jun 30, 2024 |
| BLACKROCK INC. | 4.65% | 0.00% | 2,895,613 | 1,397,432 | 93.28% | 7,383,813 | Jun 30, 2024 |
| VANGUARD GROUP INC | 2.78% | 0.00% | 1,732,133 | 593,480 | 52.12% | 4,416,940 | Jun 30, 2024 |
| DAFNA CAPITAL MANAGEMENT LLC | 2.74% | 1.04% | 1,704,232 | 396,825 | 30.35% | 4,345,792 | Jun 30, 2024 |
| OCTAGON CAPITAL ADVISORS LP | 2.14% | 0.53% | 1,333,650 | 793,650 | 146.97% | 3,400,808 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.12% | 0.01% | 1,322,751 | 1,322,751 | 100.00% | 3,373,015 | Jun 30, 2024 |
| SYNCONA PORTFOLIO LTD | 1.61% | 2.97% | 1,000,771 | 1,000,771 | 100.00% | 2,551,966 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.50% | 0.00% | 935,568 | 424,977 | 83.23% | 2,385,845 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 1.44% | 0.23% | 900,000 | - | - | 2,295,000 | Jun 30, 2024 |
| BAKER BROS. ADVISORS LP | 1.28% | 0.03% | 797,460 | - | - | 2,033,523 | Jun 30, 2024 |
| STATE STREET CORP | 1.25% | 0.00% | 779,591 | 294,373 | 60.67% | 1,987,957,000 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.64% | 0.00% | 398,380 | 246,329 | 162.00% | 1,015,869 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.61% | 0.00% | 378,633 | 21,232 | 5.94% | 965,514 | Jun 30, 2024 |
| FEDERATED HERMES, INC. | 0.44% | 0.00% | 276,163 | -338,980 | -55.11% | 704,216,000 | Jun 30, 2024 |
| MORGAN STANLEY | 0.37% | - | 228,613 | 14,233 | 6.64% | 582,963 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.34% | 0.00% | 211,326 | 26,711 | 14.47% | 538,882,000 | Jun 30, 2024 |
Century Therapeutics's largest institutional shareholder is BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC, holding 8.68% of the company's total share outstanding, currently valued at $13.80M. The top 10 institutional shareholders own together 49.52% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SYNCONA PORTFOLIO LTD | 1.61% | 2.97% | 1,000,771 | 1,000,771 | 100.00% | 2,551,966 | Jun 30, 2024 |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 8.68% | 1.51% | 5,410,361 | 5,410,361 | 100.00% | 13,796,421 | Jun 30, 2024 |
| DAFNA CAPITAL MANAGEMENT LLC | 2.74% | 1.04% | 1,704,232 | 396,825 | 30.35% | 4,345,792 | Jun 30, 2024 |
| VR ADVISER, LLC | 8.65% | 0.88% | 5,389,259 | 1,984,126 | 58.27% | 13,742,610 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 7.87% | 0.66% | 4,901,603 | 3,151,603 | 180.09% | 12,499,088 | Jun 30, 2024 |
| CASDIN CAPITAL, LLC | 5.15% | 0.63% | 3,206,380 | - | - | 8,176,269 | Jun 30, 2024 |
| OCTAGON CAPITAL ADVISORS LP | 2.14% | 0.53% | 1,333,650 | 793,650 | 146.97% | 3,400,808 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 1.44% | 0.23% | 900,000 | - | - | 2,295,000 | Jun 30, 2024 |
| PARAMETRICA MANAGEMENT LTD | 0.04% | 0.09% | 27,840 | - | - | 70,992 | Jun 30, 2024 |
| HARBOURVEST PARTNERS LLC | 0.05% | 0.04% | 29,018 | - | - | 73,996 | Jun 30, 2024 |
| BAKER BROS. ADVISORS LP | 1.28% | 0.03% | 797,460 | - | - | 2,033,523 | Jun 30, 2024 |
| CORNERCAP INVESTMENT COUNSEL INC | 0.08% | 0.02% | 51,015 | -505 | -0.98% | 130,088 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.25% | 0.01% | 157,600 | 40,000 | 34.01% | 401,880 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.12% | 0.01% | 1,322,751 | 1,322,751 | 100.00% | 3,373,015 | Jun 30, 2024 |
| FOUNDERS FINANCIAL SECURITIES LLC | 0.02% | 0.00% | 10,000 | - | - | 25,500 | Jun 30, 2024 |
| FEDERATED HERMES, INC. | 0.44% | 0.00% | 276,163 | -338,980 | -55.11% | 704,216,000 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.03% | 0.00% | 17,032 | 12,676 | 291.00% | 43,432 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.27% | 0.00% | 165,500 | 9,500 | 6.09% | 422,025 | Jun 30, 2024 |
| FMR LLC | 4.74% | 0.00% | 2,950,279 | -420,949 | -12.49% | 7,523,211 | Jun 30, 2024 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 0.13% | 0.00% | 78,234 | 19 | 0.02% | 199,497 | Jun 30, 2024 |
The largest Century Therapeutics shareholder by % of total assets is SYNCONA PORTFOLIO LTD. The company owns 1.00M shares of Century Therapeutics (IPSC), representing 2.97% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 8.68% | 1.51% | 5,410,361 | 5,410,361 | 100.00% | 13,796,421 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 7.87% | 0.66% | 4,901,603 | 3,151,603 | 180.09% | 12,499,088 | Jun 30, 2024 |
| VR ADVISER, LLC | 8.65% | 0.88% | 5,389,259 | 1,984,126 | 58.27% | 13,742,610 | Jun 30, 2024 |
| BLACKROCK INC. | 4.65% | 0.00% | 2,895,613 | 1,397,432 | 93.28% | 7,383,813 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.12% | 0.01% | 1,322,751 | 1,322,751 | 100.00% | 3,373,015 | Jun 30, 2024 |
| SYNCONA PORTFOLIO LTD | 1.61% | 2.97% | 1,000,771 | 1,000,771 | 100.00% | 2,551,966 | Jun 30, 2024 |
| OCTAGON CAPITAL ADVISORS LP | 2.14% | 0.53% | 1,333,650 | 793,650 | 146.97% | 3,400,808 | Jun 30, 2024 |
| VANGUARD GROUP INC | 2.78% | 0.00% | 1,732,133 | 593,480 | 52.12% | 4,416,940 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.50% | 0.00% | 935,568 | 424,977 | 83.23% | 2,385,845 | Jun 30, 2024 |
| DAFNA CAPITAL MANAGEMENT LLC | 2.74% | 1.04% | 1,704,232 | 396,825 | 30.35% | 4,345,792 | Jun 30, 2024 |
| STATE STREET CORP | 1.25% | 0.00% | 779,591 | 294,373 | 60.67% | 1,987,957,000 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.64% | 0.00% | 398,380 | 246,329 | 162.00% | 1,015,869 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.24% | 0.00% | 149,000 | 78,088 | 110.12% | 379,951 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.17% | 0.00% | 105,650 | 45,611 | 75.97% | 269,408 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 0.12% | 0.00% | 75,315 | 44,155 | 141.70% | 191,988 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.25% | 0.01% | 157,600 | 40,000 | 34.01% | 401,880 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.11% | - | 70,806 | 31,523 | 80.25% | 180,555 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.34% | 0.00% | 211,326 | 26,711 | 14.47% | 538,882,000 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.04% | 0.00% | 24,683 | 24,683 | 100.00% | 62,942 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.61% | 0.00% | 378,633 | 21,232 | 5.94% | 965,514 | Jun 30, 2024 |
As of Jun 30 2024, Century Therapeutics's largest institutional buyer is BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC. The company purchased 5.41M stocks of IPSC, valued at $13.80M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AVIDITY PARTNERS MANAGEMENT LP | - | - | - | -1,221,555 | -100.00% | - | Jun 30, 2024 |
| FMR LLC | 4.74% | 0.00% | 2,950,279 | -420,949 | -12.49% | 7,523,211 | Jun 30, 2024 |
| FEDERATED HERMES, INC. | 0.44% | 0.00% | 276,163 | -338,980 | -55.11% | 704,216,000 | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.02% | 0.00% | 10,583 | -283,358 | -96.40% | 26,987 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | - | - | - | -93,085 | -100.00% | - | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | - | - | - | -22,330 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -18,907 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | 0.02% | - | 14,095 | -14,623 | -50.92% | 35,942 | Jun 30, 2024 |
| OCCUDO QUANTITATIVE STRATEGIES LP | - | - | - | -13,562 | -100.00% | - | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.05% | - | 29,598 | -12,745 | -30.10% | 75,474 | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -11,543 | -100.00% | - | Jun 30, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | - | - | - | -11,130 | -100.00% | - | Jun 30, 2024 |
| ABEL HALL, LLC | - | - | - | -10,071 | -100.00% | - | Jun 30, 2024 |
| POINT72 (DIFC) LTD | - | - | - | -6,435 | -100.00% | - | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.03% | - | 20,057 | -5,623 | -21.90% | 51,145 | Jun 30, 2024 |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | 0.00% | - | 100 | -4,241 | -97.70% | 255 | Jun 30, 2024 |
| COMERICA BANK | - | - | - | -2,946 | -100.00% | - | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 0.01% | - | 7,261 | -2,473 | -25.41% | 18,516 | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -2,420 | -100.00% | - | Jun 30, 2024 |
| CORNERCAP INVESTMENT COUNSEL INC | 0.08% | 0.02% | 51,015 | -505 | -0.98% | 130,088 | Jun 30, 2024 |
As of Jun 30 2024, Century Therapeutics's biggest institutional seller is AVIDITY PARTNERS MANAGEMENT LP. The company sold -1.22M shares of IPSC, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 8.68% | 1.51% | 5,410,361 | 5,410,361 | 100.00% | 13,796,421 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.12% | 0.01% | 1,322,751 | 1,322,751 | 100.00% | 3,373,015 | Jun 30, 2024 |
| SYNCONA PORTFOLIO LTD | 1.61% | 2.97% | 1,000,771 | 1,000,771 | 100.00% | 2,551,966 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.04% | 0.00% | 24,683 | 24,683 | 100.00% | 62,942 | Jun 30, 2024 |
| VOYA INVESTMENT MANAGEMENT LLC | 0.03% | 0.00% | 17,437 | 17,437 | 100.00% | 44,464 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.02% | - | 14,882 | 14,882 | 100.00% | 38,000 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.02% | 0.00% | 11,389 | 11,389 | 100.00% | 29,042 | Jun 30, 2024 |
Century Therapeutics's largest new institutional shareholder by number of shares is BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC, purchased 5.41M shares, valued at $13.80M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AVIDITY PARTNERS MANAGEMENT LP | - | - | - | -1,221,555 | -100.00% | - | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | - | - | - | -93,085 | -100.00% | - | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | - | - | - | -22,330 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -18,907 | -100.00% | - | Jun 30, 2024 |
| OCCUDO QUANTITATIVE STRATEGIES LP | - | - | - | -13,562 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -11,543 | -100.00% | - | Jun 30, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | - | - | - | -11,130 | -100.00% | - | Jun 30, 2024 |
| ABEL HALL, LLC | - | - | - | -10,071 | -100.00% | - | Jun 30, 2024 |
| POINT72 (DIFC) LTD | - | - | - | -6,435 | -100.00% | - | Jun 30, 2024 |
| COMERICA BANK | - | - | - | -2,946 | -100.00% | - | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -2,420 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -334 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -6 | -100.00% | - | Jun 30, 2024 |
Century Therapeutics's largest sold out institutional shareholder by shares sold is AVIDITY PARTNERS MANAGEMENT LP, sold -1.22M shares, valued at -, as of undefined.
Century Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| FIDELITY MT VERNON STREET TRUST | 0.06% | 1,785,234 | -130,261 | -6.80% | Feb 29, 2024 |
| Collaborative Investment Series Trust | 0.05% | 8,232 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.04% | 118,000 | - | - | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.04% | 103,800 | - | - | Mar 28, 2024 |
| IndexIQ ETF Trust | 0.04% | 93,402 | -6,909 | -6.89% | Jan 31, 2024 |
| Federated Hermes Equity Funds | 0.03% | 543,000 | - | - | Jan 31, 2024 |
| ROYCE MICRO-CAP TRUST, INC. | 0.02% | 11,430 | - | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.01% | 7,713 | - | - | Mar 31, 2024 |
| PFM Multi-Manager Series Trust | 0.01% | 8,468 | - | - | Dec 31, 2023 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 47,754 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 4,162 | - | - | Mar 31, 2024 |
| FIDELITY CAPITAL TRUST | 0.01% | 76,426 | - | - | Jan 31, 2024 |
| FIDELITY SECURITIES FUND | 0.01% | 542,157 | - | - | Jan 31, 2024 |
| Fidelity Central Investment Portfolios LLC | 0.00% | 240,000 | - | - | Feb 29, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.00% | 10,194 | - | - | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND | 0.00% | 65,000 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 928,021 | -296,902 | -24.24% | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 135,018 | - | - | Feb 29, 2024 |
| FEDERATED HERMES INSURANCE SERIES | 0.00% | 7,000 | - | - | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 298 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 53,526 | - | - | Jan 31, 2024 |
| Managed Portfolio Series | 0.00% | 25,978 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 223,825 | 14,487 | 6.92% | Feb 29, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 6,161 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 13,813 | - | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 905 | - | - | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,421 | 809 | 132.19% | Mar 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 70,873 | 368 | 0.52% | Feb 29, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 9,212 | 250 | 2.79% | Mar 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.00% | 1,594 | - | - | Jan 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 98,301 | 3,654 | 3.86% | Feb 29, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 397 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 8,300 | 2,700 | 48.21% | Mar 31, 2024 |
| LoCorr Investment Trust | 0.00% | 2,700 | - | - | Mar 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 14,026 | 10,912 | 350.42% | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 1,058 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 8,556 | -1,364 | -13.75% | Mar 28, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 1,338 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 852,329 | -51,068 | -5.65% | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 102,994 | 13,103 | 14.58% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 214 | - | - | Dec 31, 2023 |
| EQ ADVISORS TRUST | 0.00% | 51,761 | 120 | 0.23% | Mar 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 2,446 | - | - | Feb 29, 2024 |
| VALIC Co I | 0.00% | 8,989 | -36 | -0.40% | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 800 | - | - | Mar 28, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 106 | - | - | Dec 31, 2023 |
| Fidelity Rutland Square Trust II | 0.00% | 27,180 | - | - | Feb 29, 2024 |
| MORGAN STANLEY INSTITUTIONAL FUND INC | 0.00% | 1,455 | - | - | Mar 31, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 1,100 | - | - | Dec 31, 2023 |
| TIAA-CREF FUNDS | 0.00% | 58,257 | - | - | Jan 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 96 | - | - | Feb 29, 2024 |
| ProFunds | 0.00% | 181 | -15 | -7.65% | Mar 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 2,025 | -28 | -1.36% | Jan 31, 2024 |
| PROSHARES TRUST | 0.00% | 3,431 | -3,407 | -49.82% | Feb 29, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 14 | - | - | Dec 31, 2023 |
| PACE SELECT ADVISORS TRUST | 0.00% | 3,700 | - | - | Jan 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 2,627 | - | - | Jan 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,003 | - | - | Feb 29, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 22,100 | - | - | Mar 31, 2024 |
| ADVANCED SERIES TRUST | 0.00% | 29,040 | - | - | Mar 28, 2024 |
| Brighthouse Funds Trust II | 0.00% | 7,830 | - | - | Mar 31, 2024 |
| MUTUAL FUND SERIES TRUST | 0.00% | 35,000 | - | - | Mar 31, 2024 |
| J.P. Morgan Exchange-Traded Fund Trust | 0.00% | 3,273 | - | - | Jan 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 2,654 | -10 | -0.38% | Jan 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 5,939 | 2,308 | 63.56% | Jan 31, 2024 |
| ALLSPRING FUNDS TRUST | 0.00% | 2,092 | - | - | Jan 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 17,549 | -262 | -1.47% | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 419 | - | - | Feb 29, 2024 |
| ETF Series Solutions | 0.00% | 71 | - | - | Jan 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 1,007 | - | - | Jan 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 6,971 | 6,132 | 730.87% | Mar 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 9,095 | - | - | Mar 31, 2024 |
| Bridge Builder Trust | 0.00% | 9,924 | - | - | Mar 31, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 5,600 | - | - | Dec 31, 2023 |
| COLUMBIA FUNDS SERIES TRUST I | 0.00% | 7,793 | -17,435 | -69.11% | Feb 29, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 1,418 | - | - | Dec 31, 2023 |
| Blackstone Alternative Investment Funds | 0.00% | 100 | - | - | Mar 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 682 | - | - | Mar 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 2,259 | - | - | Mar 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 3,205 | - | - | Jan 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 2,939 | 578 | 24.48% | Jan 31, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 2,500 | - | - | Feb 29, 2024 |
Century Therapeutics's largest mutual fund holder by % of total assets is "FIDELITY MT VERNON STREET TRUST", owning 1.79M shares, compromising 0.06% of its total assets.
Century Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 16 | -76.12% |
| 31 Mar, 24 | 67 | 6.35% |
| 31 Dec, 23 | 63 | 14.55% |
| 30 Sep, 23 | 55 | -15.38% |
| 30 Jun, 23 | 65 | - |
| 31 Mar, 23 | 65 | -4.41% |
| 31 Dec, 22 | 68 | 23.64% |
| 30 Sep, 22 | 55 | 1.85% |
| 30 Jun, 22 | 54 | 5.88% |
| 31 Mar, 22 | 51 | 2.00% |
| 31 Dec, 21 | 50 | 2.04% |
| 30 Sep, 21 | 49 | 40.00% |
| 30 Jun, 21 | 35 | - |
As of 30 Jun 24, 16 institutions are holding Century Therapeutics's shares, representing a decrease of -76.12% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 1,958,268 | -91.52% |
| 31 Mar, 24 | 23,106,280 | 30.72% |
| 31 Dec, 23 | 17,675,612 | -2.13% |
| 30 Sep, 23 | 18,061,121 | -6.38% |
| 30 Jun, 23 | 19,290,944 | -3.63% |
| 31 Mar, 23 | 20,017,313 | -4.19% |
| 31 Dec, 22 | 20,893,189 | -0.97% |
| 30 Sep, 22 | 21,098,128 | -3.03% |
| 30 Jun, 22 | 21,757,245 | -1.78% |
| 31 Mar, 22 | 22,151,837 | 4.80% |
| 31 Dec, 21 | 21,137,626 | 6.76% |
| 30 Sep, 21 | 19,798,823 | 17.28% |
| 30 Jun, 21 | 16,881,896 | - |
Century Therapeutics (IPSC) has 1.96M shares outstanding as of 30 Jun 24, down -91.52% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 3.14% | 0.21% |
| 31 Mar, 24 | 38.96% | 4.41% |
| 31 Dec, 23 | 29.73% | 3.20% |
| 30 Sep, 23 | 30.48% | 2.81% |
| 30 Jun, 23 | 32.91% | 2.82% |
| 31 Mar, 23 | 34.15% | 2.61% |
| 31 Dec, 22 | 36.17% | 2.73% |
| 30 Sep, 22 | 36.39% | 2.56% |
| 30 Jun, 22 | 37.72% | 2.50% |
| 31 Mar, 22 | 38.83% | 0.91% |
| 31 Dec, 21 | 65.25% | 1.75% |
| 30 Sep, 21 | 61.12% | 2.25% |
| 30 Jun, 21 | 52.12% | - |
As of 30 Jun 24, Century Therapeutics is held by 3.14% institutional shareholders, representing a 0.21% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 10 | -64.29% |
| 31 Mar, 24 | 28 | -17.65% |
| 31 Dec, 23 | 34 | 70.00% |
| 30 Sep, 23 | 20 | -16.67% |
| 30 Jun, 23 | 24 | -36.84% |
| 31 Mar, 23 | 38 | -9.52% |
| 31 Dec, 22 | 42 | 55.56% |
| 30 Sep, 22 | 27 | -10.00% |
| 30 Jun, 22 | 30 | 3.45% |
| 31 Mar, 22 | 29 | -9.38% |
| 31 Dec, 21 | 32 | -8.57% |
| 30 Sep, 21 | 35 | - |
| 30 Jun, 21 | 35 | - |
10 institutional shareholders have increased their position in IPSC stock as of 30 Jun 24 compared to 28 in the previous quarter (a -64.29% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 2 | -90.91% |
| 31 Mar, 24 | 22 | 10.00% |
| 31 Dec, 23 | 20 | - |
| 30 Sep, 23 | 20 | -16.67% |
| 30 Jun, 23 | 24 | 41.18% |
| 31 Mar, 23 | 17 | 41.67% |
| 31 Dec, 22 | 12 | -25.00% |
| 30 Sep, 22 | 16 | 60.00% |
| 30 Jun, 22 | 10 | - |
| 31 Mar, 22 | 10 | 42.86% |
| 31 Dec, 21 | 7 | -12.50% |
| 30 Sep, 21 | 8 | - |
| 30 Jun, 21 | - | - |
2 institutional shareholders have reduced their position in IPSC stock as of 30 Jun 24 compared to 22 in the previous quarter (a -90.91% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 16 | -76.12% | 1,958,268 | -91.52% | 3.14% | 0.21% | 10 | -64.29% | 2 | -90.91% |
| 31 Mar, 24 | 67 | 6.35% | 23,106,280 | 30.72% | 38.96% | 4.41% | 28 | -17.65% | 22 | 10.00% |
| 31 Dec, 23 | 63 | 14.55% | 17,675,612 | -2.13% | 29.73% | 3.20% | 34 | 70.00% | 20 | - |
| 30 Sep, 23 | 55 | -15.38% | 18,061,121 | -6.38% | 30.48% | 2.81% | 20 | -16.67% | 20 | -16.67% |
| 30 Jun, 23 | 65 | - | 19,290,944 | -3.63% | 32.91% | 2.82% | 24 | -36.84% | 24 | 41.18% |
| 31 Mar, 23 | 65 | -4.41% | 20,017,313 | -4.19% | 34.15% | 2.61% | 38 | -9.52% | 17 | 41.67% |
| 31 Dec, 22 | 68 | 23.64% | 20,893,189 | -0.97% | 36.17% | 2.73% | 42 | 55.56% | 12 | -25.00% |
| 30 Sep, 22 | 55 | 1.85% | 21,098,128 | -3.03% | 36.39% | 2.56% | 27 | -10.00% | 16 | 60.00% |
| 30 Jun, 22 | 54 | 5.88% | 21,757,245 | -1.78% | 37.72% | 2.50% | 30 | 3.45% | 10 | - |
| 31 Mar, 22 | 51 | 2.00% | 22,151,837 | 4.80% | 38.83% | 0.91% | 29 | -9.38% | 10 | 42.86% |
| 31 Dec, 21 | 50 | 2.04% | 21,137,626 | 6.76% | 65.25% | 1.75% | 32 | -8.57% | 7 | -12.50% |
| 30 Sep, 21 | 49 | 40.00% | 19,798,823 | 17.28% | 61.12% | 2.25% | 35 | - | 8 | - |
| 30 Jun, 21 | 35 | - | 16,881,896 | - | 52.12% | - | 35 | - | - | - |
Century Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Century Therapeutics's stock was made by Farid Adrienne on Aug 07 2024, selling 1,073 shares at $1.83 per share (valued at $1.96K).
Century Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 5 | - |
| Q2 2024 | 8 | 7 | 114.29% |
| Q1 2024 | 13 | 10 | 130.00% |
| Q4 2023 | 3 | 2 | 150.00% |
| Q2 2023 | 12 | 3 | 400.00% |
| Q1 2023 | 17 | 6 | 283.33% |
| Q4 2022 | 2 | - | - |
| Q3 2022 | - | 4 | - |
| Q2 2022 | 9 | - | - |
| Q1 2022 | 7 | 1 | 700.00% |
| Q4 2021 | - | 1 | - |
| Q2 2021 | 15 | 32 | 46.88% |
0 total buy trades, and 5 total sell trades (buy/sell ratio of 0.00%) were made by Century Therapeutics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 5 | - |
| Q2 2024 | - | 7 | - |
| Q1 2024 | - | 7 | - |
| Q4 2023 | - | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | 3 | - |
| Q4 2022 | - | - | - |
| Q3 2022 | - | 2 | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | - | - |
| Q2 2021 | 3 | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 5 open market sell trades of Century Therapeutics's stocks.
Century Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| NGM | NGM Biopharmaceuticals, Inc. |
| CGEM | Cullinan Oncology, Inc. |
| BPMC | Blueprint Medicines Corporation |
| MLYS | Mineralys Therapeutics, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| STOK | Stoke Therapeutics, Inc. |
| ERAS | Erasca, Inc. |
| GBIO | Generation Bio Co. |
| RLAY | Relay Therapeutics, Inc. |
| PASG | Passage Bio, Inc. |
| KROS | Keros Therapeutics, Inc. |
| CCCC | C4 Therapeutics, Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| NKTX | Nkarta, Inc. |
| KZR | Kezar Life Sciences, Inc. |
| FIXX | Q32 Bio Inc. |
| LIFE | aTyr Pharma, Inc. |
IPSC Ownership FAQ
Who Owns Century Therapeutics?
Century Therapeutics is owned by institutional shareholders (3.14%), insiders (28.21%), and public (68.64%). The largest institutional shareholder of Century Therapeutics is BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC (8.68% of total shares) and the top mutual fund owner is FIDELITY MT VERNON STREET TRUST (0.06% of total shares).
Who are the major institutional shareholders of Century Therapeutics?
Century Therapeutics's major institutional shareholders are BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC, VR ADVISER, LLC, BOXER CAPITAL, LLC, CASDIN CAPITAL, LLC, and FMR LLC. The top five shareholders own together 35.09% of the company's share outstanding.
How many Century Therapeutics shareholders are there?
As of Jun 2024, there are 16 institutional shareholders of Century Therapeutics.
What percentage of Century Therapeutics is owned by BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC?
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC owns 5.41M shares of Century Therapeutics, representing 8.68% of the company's total shares outstanding, valued at $13.8M (as of Jun 2024).
What percentage of Century Therapeutics is owned by VR ADVISER, LLC?
As of Jun 2024, VR ADVISER, LLC holds 5.39M shares of Century Therapeutics (IPSC), compromising 8.65% of the company, valued at $13.74M.
What percentage of Century Therapeutics is owned by BOXER CAPITAL, LLC?
BOXER CAPITAL, LLC is the third largest holder of Century Therapeutics. The company owns 4.9M of the company's shares outstanding (worth $12.5M).